Active Ingredient History
Phosphoric acid, also known as orthophosphoric acid, is used in dentistry and orthodontics to clean and roughen the surfaces of teeth where dental appliances or fillings will be placed. In addition, this acid is a part of product ProcalAmine, which is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well-nourished, mildly catabolic patients who require short-term parenteral nutrition. In combination with dextrose (glucose) and levulose (fructose), phosphoric acid relieves nausea due to upset stomach from intestinal flu, stomach flu, and food or drink indiscretions. In addition, homeopathic product, Brain power contains also phosphoric acid and this product is used to temporarily relieve symptoms of general physical weakness and listlessness, including: fatigue; sore muscles & joints; dry skin; absence of sexual desire; occasional sleeplessness. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alzheimer Disease (Phase 2)
Angioedema (Phase 3)
Bronchopulmonary Dysplasia (Phase 1)
COVID-19 (Phase 1/Phase 2)
COVID-19 Vaccines (Phase 1/Phase 2)
Critical Care (Phase 4)
Familial Hypophosphatemic Rickets (Phase 3)
Fatigue ()
Genetic Diseases, X-Linked (Early Phase 1)
Head and Neck Neoplasms (Phase 4)
Healthy Volunteers (Phase 1/Phase 2)
Hodgkin Disease (Phase 2)
Hypercalciuria (Early Phase 1)
Hypoparathyroidism (Phase 4)
Hypophosphatemia (Early Phase 1)
Influenza A Virus, H7N9 Subtype (Phase 1/Phase 2)
Influenza, Human (Phase 3)
Irritable Bowel Syndrome (Phase 4)
Leukemia, Myeloid, Acute (Phase 2)
Lupus Erythematosus, Systemic (Phase 3)
Lupus Nephritis (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Myalgia ()
Myelodysplastic Syndromes (Phase 2)
Nausea ()
Pneumonia, Viral (Phase 1/Phase 2)
Prostheses and Implants (Phase 2)
Refeeding Syndrome (Phase 4)
Respiratory Syncytial Viruses (Phase 2)
Respiratory Syncytial Virus Infections (Phase 3)
Rickets (Early Phase 1)
Severe Acute Respiratory Syndrome (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue